STOCK TITAN

Lci Inds Financials

LCII
Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Lci Inds (LCII) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI LCII FY2025

Margin recovery is outrunning the sales rebound, but working capital is still soaking up cash as volume rebuilds.

In the latest year, net income climbed from $143M to $188M, but operating cash flow moved the other way. With inventory and receivables up a combined $116M, the rebound looks working-capital hungry—a reversal of the prior two years, when cash generation outpaced earnings.

Revenue is still about $1.1B below the recent peak, so the top line has not fully normalized. Yet gross margin recovered to 23.8%, close to the prior peak's 24.5%, which points to margin repair ahead of full volume recovery and suggests the earnings hit was partly a utilization problem, not only weaker demand.

Near-term liquidity still looks comfortable, with a current ratio of 2.9x and cash of $223M available for day-to-day needs. But long-term debt increased by $185M while dividends and buybacks used about 87.2% of free cash flow, showing a less defensive balance-sheet posture as conditions improved.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 50 / 100
Financial Profile 50/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Lci Inds's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
35

Lci Inds has an operating margin of 6.8%, meaning the company retains $7 of operating profit per $100 of revenue. This results in a moderate score of 35/100, indicating healthy but not exceptional operating efficiency. This is up from 5.8% the prior year.

Growth
41

Lci Inds's revenue grew 10.2% year-over-year to $4.1B, a solid pace of expansion. This earns a growth score of 41/100.

Leverage
88

Lci Inds carries a low D/E ratio of 0.69, meaning only $0.69 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 88/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
54

Lci Inds's current ratio of 2.85 indicates adequate short-term liquidity, earning a score of 54/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow
46

Lci Inds has a free cash flow margin of 6.8%, earning a moderate score of 46/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
35

Lci Inds's ROE of 13.8% shows moderate profitability relative to equity, earning a score of 35/100. This is up from 10.3% the prior year.

Altman Z-Score Safe
3.38

Lci Inds scores 3.38, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Piotroski F-Score Strong
8/9

Lci Inds passes 8 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed
1.76x

For every $1 of reported earnings, Lci Inds generates $1.76 in operating cash flow ($331.0M OCF vs $188.3M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe
7.8x

Lci Inds earns $7.8 in operating income for every $1 of interest expense ($279.9M vs $35.7M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$4.1B
YoY+10.2%
5Y CAGR+8.1%
10Y CAGR+11.4%

Lci Inds generated $4.1B in revenue in fiscal year 2025. This represents an increase of 10.2% from the prior year.

EBITDA
$401.2M
YoY+16.6%
5Y CAGR+4.6%
10Y CAGR+9.8%

Lci Inds's EBITDA was $401.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 16.6% from the prior year.

Net Income
$188.3M
YoY+31.8%
5Y CAGR+3.5%
10Y CAGR+9.7%

Lci Inds reported $188.3M in net income in fiscal year 2025. This represents an increase of 31.8% from the prior year.

EPS (Diluted)
$7.57
YoY+35.2%
5Y CAGR+3.8%
10Y CAGR+9.6%

Lci Inds earned $7.57 per diluted share (EPS) in fiscal year 2025. This represents an increase of 35.2% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$278.3M
YoY-15.1%
5Y CAGR+9.8%
10Y CAGR+15.5%

Lci Inds generated $278.3M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 15.1% from the prior year.

Cash & Debt
$222.6M
YoY+34.3%
5Y CAGR+33.8%
10Y CAGR+33.6%

Lci Inds held $222.6M in cash against $941.5M in long-term debt as of fiscal year 2025.

Dividends Per Share
$4.60
YoY+7.0%
5Y CAGR+10.4%
10Y CAGR+8.7%

Lci Inds paid $4.60 per share in dividends in fiscal year 2025. This represents an increase of 7.0% from the prior year.

Shares Outstanding
24M
YoY-5.0%
5Y CAGR-0.8%

Lci Inds had 24M shares outstanding in fiscal year 2025. This represents a decrease of 5.0% from the prior year.

Margins & Returns

Gross Margin
23.8%
YoY+0.3pp
5Y CAGR-1.5pp
10Y CAGR+2.0pp

Lci Inds's gross margin was 23.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.3 percentage points from the prior year.

Operating Margin
6.8%
YoY+1.0pp
5Y CAGR-1.2pp
10Y CAGR-1.5pp

Lci Inds's operating margin was 6.8% in fiscal year 2025, reflecting core business profitability. This is up 1.0 percentage points from the prior year.

Net Margin
4.6%
YoY+0.8pp
5Y CAGR-1.1pp
10Y CAGR-0.7pp

Lci Inds's net profit margin was 4.6% in fiscal year 2025, showing the share of revenue converted to profit. This is up 0.8 percentage points from the prior year.

Return on Equity
13.8%
YoY+3.5pp
5Y CAGR-3.6pp
10Y CAGR-3.1pp

Lci Inds's ROE was 13.8% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 3.5 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
$128.6M

Lci Inds spent $128.6M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures
$52.6M
YoY+24.4%
5Y CAGR-1.7%
10Y CAGR+6.1%

Lci Inds invested $52.6M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 24.4% from the prior year.

LCII Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue $1.1B+16.9% $932.7M-10.0% $1.0B-6.4% $1.1B+5.9% $1.0B+30.2% $803.1M-12.3% $915.5M-13.2% $1.1B
Cost of Revenue $816.9M+12.4% $726.8M-7.3% $783.9M-6.4% $837.2M+5.5% $793.8M+25.3% $633.7M-8.9% $695.5M-11.7% $788.1M
Gross Profit $273.7M+32.9% $205.9M-18.5% $252.6M-6.4% $270.0M+7.3% $251.7M+48.6% $169.4M-23.0% $220.0M-17.4% $266.4M
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $122.6M+699.1% $15.3M-91.3% $177.2M-2.8% $182.2M+51.1% $120.6M+379.0% -$43.2M-126.0% $166.1M-5.6% $175.8M
Operating Income $95.2M+169.1% $35.4M-53.1% $75.4M-14.1% $87.8M+8.0% $81.3M+404.0% $16.1M-70.1% $53.9M-40.5% $90.6M
Interest Expense -$9.9M-116.1% $61.7M+697.8% -$10.3M-6.5% -$9.7M-61.7% -$6.0M-111.4% $52.7M+908.7% -$6.5M+18.2% -$8.0M
Income Tax $22.3M+219.9% $7.0M-67.6% $21.5M+5.1% $20.5M+14.8% $17.8M+1099.4% $1.5M-87.4% $11.8M-45.2% $21.5M
Net Income $62.9M+236.9% $18.7M-70.1% $62.5M+8.4% $57.6M+16.6% $49.4M+417.8% $9.5M-73.2% $35.6M-41.8% $61.2M
EPS (Diluted) $2.53 N/A $2.55+11.4% $2.29+18.0% $1.94 N/A $1.39-42.1% $2.40

LCII Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $3.2B+1.3% $3.2B+0.2% $3.2B-0.2% $3.2B+2.4% $3.1B+7.1% $2.9B-4.3% $3.0B+0.4% $3.0B
Current Assets $1.4B+5.2% $1.3B-1.4% $1.4B+0.8% $1.4B-0.6% $1.4B+17.8% $1.2B-6.8% $1.2B+2.1% $1.2B
Cash & Equivalents $142.2M-36.1% $222.6M+11.5% $199.7M+4.1% $191.9M-17.0% $231.2M+39.5% $165.8M+2.8% $161.2M+23.6% $130.4M
Inventory $834.5M+3.1% $809.1M+9.1% $741.3M+4.4% $710.3M-1.0% $717.4M-2.6% $736.6M+4.4% $705.4M+2.6% $687.9M
Accounts Receivable $376.1M+54.5% $243.4M-33.1% $363.9M-5.8% $386.1M+8.1% $357.1M+79.0% $199.6M-37.5% $319.2M-4.2% $333.1M
Goodwill $619.5M-0.4% $622.2M+0.3% $620.6M+0.3% $618.9M+4.9% $590.2M+0.8% $585.8M-1.4% $593.9M+0.9% $588.5M
Total Liabilities $1.8B+0.8% $1.8B+0.5% $1.8B+1.0% $1.8B+3.2% $1.7B+15.0% $1.5B-6.1% $1.6B-0.7% $1.6B
Current Liabilities $488.0M+3.1% $473.4M-3.8% $492.2M+1.6% $484.3M+5.0% $461.3M+11.9% $412.1M-4.6% $432.0M-0.1% $432.5M
Long-Term Debt $941.3M0.0% $941.5M-0.3% $944.2M0.0% $944.3M+1.0% $934.6M+23.5% $756.8M-8.0% $822.3M-0.8% $829.2M
Total Equity $1.4B+1.9% $1.4B-0.1% $1.4B-1.7% $1.4B+1.3% $1.4B-1.5% $1.4B-2.2% $1.4B+1.7% $1.4B
Retained Earnings $1.3B+2.7% $1.3B-0.8% $1.3B+2.7% $1.3B+2.3% $1.2B+1.6% $1.2B-1.7% $1.2B+0.7% $1.2B

LCII Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow -$33.5M-142.4% $78.9M-18.8% $97.2M-13.4% $112.2M+162.7% $42.7M-59.9% $106.6M+36.0% $78.4M-59.4% $192.9M
Capital Expenditures $9.7M-33.7% $14.6M-10.6% $16.3M+28.0% $12.7M+40.9% $9.0M-17.4% $10.9M+8.8% $10.1M-20.9% $12.7M
Free Cash Flow -$43.1M-167.1% $64.3M-20.5% $80.9M-18.7% $99.5M+195.4% $33.7M-64.8% $95.7M+40.0% $68.3M-62.1% $180.2M
Investing Cash Flow -$9.6M+62.3% -$25.4M-1583.7% $1.7M+102.1% -$81.3M-93.4% -$42.0M-299.2% -$10.5M-7.1% -$9.8M+69.6% -$32.3M
Financing Cash Flow -$35.5M-21.4% -$29.3M+68.2% -$92.1M-29.8% -$71.0M-206.1% $66.9M+173.5% -$91.0M-139.0% -$38.1M+27.6% -$52.6M
Dividends Paid $27.9M+0.4% $27.8M0.0% $27.8M-4.2% $29.0M-1.1% $29.4M+0.2% $29.3M+9.5% $26.7M0.0% $26.7M
Share Buybacks $0 $0-100.0% $62.2M+63.4% $38.1M+34.8% $28.3M $0 $0 $0

LCII Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin 25.1%+3.0pp 22.1%-2.3pp 24.4%-0.0pp 24.4%+0.3pp 24.1%+3.0pp 21.1%-2.9pp 24.0%-1.2pp 25.3%
Operating Margin 8.7%+4.9pp 3.8%-3.5pp 7.3%-0.6pp 7.9%+0.2pp 7.8%+5.8pp 2.0%-3.9pp 5.9%-2.7pp 8.6%
Net Margin 5.8%+3.8pp 2.0%-4.0pp 6.0%+0.8pp 5.2%+0.5pp 4.7%+3.5pp 1.2%-2.7pp 3.9%-1.9pp 5.8%
Return on Equity 4.5%+3.2pp 1.4%-3.2pp 4.6%+0.4pp 4.2%+0.5pp 3.6%+2.9pp 0.7%-1.8pp 2.5%-1.9pp 4.4%
Return on Assets 2.0%+1.4pp 0.6%-1.4pp 2.0%+0.1pp 1.8%+0.2pp 1.6%+1.3pp 0.3%-0.9pp 1.2%-0.8pp 2.0%
Current Ratio 2.91+0.1 2.85+0.1 2.78-0.0 2.80-0.2 2.96+0.1 2.82-0.1 2.88+0.1 2.82
Debt-to-Equity 0.68-0.0 0.690.0 0.69+0.0 0.680.0 0.68+0.1 0.55-0.0 0.58-0.0 0.59
FCF Margin -4.0%-10.8pp 6.9%-0.9pp 7.8%-1.2pp 9.0%+5.8pp 3.2%-8.7pp 11.9%+4.4pp 7.5%-9.6pp 17.1%

Similar Companies

Frequently Asked Questions

Lci Inds (LCII) reported $4.1B in total revenue for fiscal year 2025. This represents a 10.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Lci Inds (LCII) revenue grew by 10.2% year-over-year, from $3.7B to $4.1B in fiscal year 2025.

Yes, Lci Inds (LCII) reported a net income of $188.3M in fiscal year 2025, with a net profit margin of 4.6%.

Lci Inds (LCII) reported diluted earnings per share of $7.57 for fiscal year 2025. This represents a 35.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Lci Inds (LCII) had EBITDA of $401.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Lci Inds (LCII) had $222.6M in cash and equivalents against $941.5M in long-term debt.

Lci Inds (LCII) had a gross margin of 23.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Lci Inds (LCII) had an operating margin of 6.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Lci Inds (LCII) had a net profit margin of 4.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Lci Inds (LCII) paid $4.60 per share in dividends during fiscal year 2025.

Lci Inds (LCII) has a return on equity of 13.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Lci Inds (LCII) generated $278.3M in free cash flow during fiscal year 2025. This represents a -15.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Lci Inds (LCII) generated $331.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Lci Inds (LCII) had $3.2B in total assets as of fiscal year 2025, including both current and long-term assets.

Lci Inds (LCII) invested $52.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, Lci Inds (LCII) spent $128.6M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Lci Inds (LCII) had 24M shares outstanding as of fiscal year 2025.

Lci Inds (LCII) had a current ratio of 2.85 as of fiscal year 2025, which is generally considered healthy.

Lci Inds (LCII) had a debt-to-equity ratio of 0.69 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Lci Inds (LCII) had a return on assets of 5.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Lci Inds (LCII) has an Altman Z-Score of 3.38, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Lci Inds (LCII) has a Piotroski F-Score of 8 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Lci Inds (LCII) has an earnings quality ratio of 1.76x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Lci Inds (LCII) has an interest coverage ratio of 7.8x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Lci Inds (LCII) scores 50 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top